Market dashboard
Nifty 500 opportunity engine
Analysis date:
2026-09-29
• Data coverage:
498/501 (99.40%)
MARKET REGIME
RISK OFF
Score 25.52/100
Above 50-SMA
18.78%
92 stocks
Above 200-SMA
41.43%
203 stocks
Trend Template
12.86%
63 stocks
Watch candidates
1
VCP engine shortlist • click to open
Market breadth
Counts + percentages. Click any metric to see the actual stocks and daily history.
VCP engine
Latest scan distribution
ML Candidate Ranking
PHASE 2B LIVE
V8 stage ranking is live. ML ranking is temporarily paused because the
latest model could not be verified against the actual
OmmAlpha-v8 training population.
Verification: no_model_run.
Rebuild V8 history and train the V8 model before scores resume.
Market: RISK OFF
0 ML-scored candidates
Run: —
Scored: —
V8 provenance guard active.
Historical score cohorts remain stored for audit, but the dashboard will not
display them unless their
ml_run_id matches a model whose actual
training CSV is exclusively OmmAlpha-v8.
No LIVE ML scores are available for the latest analysis date yet.
Run Phase 2B scoring after the daily pipeline.
Top Research Candidates
OMMALPHA RANK
Explainable ranking of strict actionable PRE_BREAKOUT candidates.
Stocks first have to pass the hard watch gates; OmmAlpha Rank then
orders the survivors using VCP quality, RSI, ADX, momentum and volume behaviour.
Market: RISK OFF
1 actionable candidates ranked
Analysis: 2026-09-29
Hard gate first, rank second:
every stock shown here must already be PRE_BREAKOUT, RS ≥ 70,
Trend Template PASS, SMA200 rising, within 15% of its 52-week high,
≤4% below its structural pivot, liquid, inside the allowed ATR range,
and free of BASE_AT_RISK / INVALIDATED status.
The OmmAlpha score ranks only those survivors.
Market regime remains context, not an automatic buy instruction.
Live Signal Monitor
AUTO
The pipeline captures qualifying V8 DEVELOPING, DEVELOPED and PRE_BREAKOUT watch setups automatically.
This monitor tells you what happened without opening another page.
PRE_BREAKOUT now
2
Live eligible now
1
Captured this scan
0
Pending outcomes
80
1 live-eligible setup detected.
Diagnose
| Date | Symbol | VCP | RS | Pivot | Entry | Outcome | R | Chart |
|---|---|---|---|---|---|---|---|---|
| 2026-09-28 | THELEELA | 78.20 | 88.52 | 557.00 | — | PENDING | — | View |
| 2026-09-28 | MOTHERSON | 71.60 | 90.98 | 165.58 | — | PENDING | — | View |
| 2026-09-28 | CPPLUS | 69.00 | 99.80 | 3,900.00 | — | PENDING | — | View |
| 2026-09-25 | ZYDUSLIFE | 53.20 | 78.44 | 1,205.00 | 1,210.70 | PENDING | — | View |
| 2026-09-25 | WOCKPHARMA | 44.10 | 97.95 | 2,360.00 | — | PENDING | — | View |
Current watch candidates
Ranked by VCP score, relative strength and proximity to pivot. A watch candidate is research output, not a trade instruction.
1 shown
| Symbol | Status | VCP | RSI-14 | ADX | BB Width | Rel Vol | Base Depth | RS | ML TARGET | ML Trigger | Momentum | vs 50-SMA | vs 200-SMA | Pivot | To Pivot | Contractions | Final C. | Volume Dry | ATR % | From 52W High | Trend Template | Chart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLAND | PRE_BREAKOUT | 97.40 | 60.34 | 26.18 | 5.99% | 1.45x | 22.71% | 96.32 | — | — | 45.20 | 7.12% | 39.73% | 3,042.00 | -1.87% | 4 | 4.42% | YES | 2.78% | -1.87% | PASS | View |
Recent market regime history
Useful for seeing whether participation is improving or deteriorating
| Date | 50-SMA | 200-SMA | Trend Template | Score | Regime |
|---|---|---|---|---|---|
| 2026-09-29 | 18.78% | 41.43% | 12.86% | 25.52 | WEAK |
| 2026-09-28 | 19.63% | 42.94% | 11.86% | 26.24 | WEAK |
| 2026-09-25 | 28.69% | 46.31% | 15.98% | 32.32 | WEAK |
| 2026-09-24 | 28.69% | 45.90% | 16.39% | 32.25 | WEAK |
| 2026-09-23 | 36.89% | 51.43% | 18.65% | 38.33 | WEAK |
| 2026-09-22 | 32.46% | 50.20% | 16.33% | 35.44 | WEAK |
| 2026-09-21 | 33.47% | 50.60% | 17.34% | 36.24 | WEAK |
Data health
Last raw candle date versus last analyzed complete session
Raw latest candle
2026-09-29
Stocks on raw latest date
498
Analyzed session
2026-09-29
Valid indicators
490
Research tools
The v2 layer is for measurement, validation and learning from outcomes.